
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
La Jolla Pharmaceutical Company, a subsidiary of Innoviva, Inc., is dedicated to the commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases. La Jolla markets GIAPREZA (angiotensin II) injection and XERAVA (eravacycline) for injection. For more information, please visit www.ljpc.com
La jolla pharmaceutical company operates in the Biotechnology research industry.
La jolla pharmaceutical company's revenue is 11m - 100m
La jolla pharmaceutical company has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.